Ambiguous melanocytic tumors with loss of 3p21
- PMID: 24705312
- PMCID: PMC4101029
- DOI: 10.1097/PAS.0000000000000209
Ambiguous melanocytic tumors with loss of 3p21
Abstract
Germline loss-of-function mutations in BAP1 are associated with the development of cutaneous melanocytic tumors with some histopathologic characteristics seen in Spitz nevi. Similar melanocytic tumors occurring in a sporadic setting have been demonstrated to have biallelic loss of BAP1. In some of these sporadic tumors, loss of BAP1 occurs through mutation of 1 allele and genomic loss of the other. We screened our database of comparative genomic hybridization profiles of ambiguous melanocytic tumors to identify cases with a single genomic event involving loss of the BAP1 locus. The prevalence of tumors with a single genomic event involving loss of BAP1 was 6.7% in our study population. We further characterized the BAP1 status in 17 of these tumors with available additional material, confirming loss of BAP1 in all cases. We describe BAP1 loss in a blue nevus-like melanoma and further expand the histopathologic spectrum of spitzoid melanocytic neoplasms with BAP1 loss.
Conflict of interest statement
Conflicts of interest: The author(s) have no conflicts of interest or funding to disclose.
Figures
Comment in
-
BAP1-inactivated spitzoid naevi.Am J Surg Pathol. 2015 May;39(5):722. doi: 10.1097/PAS.0000000000000407. Am J Surg Pathol. 2015. PMID: 25871468 No abstract available.
References
-
- Jensen DE, Proctor M, Marquis ST, et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene. 1998;16(9):1097–1112. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
